These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6762771)

  • 21. Prevention of coronary heart disease. A Westerner looks East.
    Turner RW
    Indian Heart J; 1973 Apr; 25(2):79-85. PubMed ID: 4726267
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical evaluation of cardiac rehabilitation. Conference summary.
    Wenger NK
    Bibl Cardiol; 1976; (36):181-4. PubMed ID: 1029455
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of metoprolol in increasing the tolerance of patients with ischemic heart disease to exertion].
    Nicolaescu V; Câmpeanu A; Pleşea O; Serban-Pârâu G; Chirilă L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(6):517-24. PubMed ID: 2882582
    [No Abstract]   [Full Text] [Related]  

  • 25. Panel discussion: the potential for preventing disease associated with hypertension.
    Lovell RR; Doyle AE; McCall M; Stephens WB; Leighton P
    Med J Aust; 1973 Aug; 2(1):Suppl:15-8. PubMed ID: 4791237
    [No Abstract]   [Full Text] [Related]  

  • 26. Exercise and coronary heart disease.
    Colbourn AW
    Del Med J; 1982 Jun; 54(6):363-6. PubMed ID: 7106332
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertension in the elderly.
    O'Sullivan J
    Aust Fam Physician; 1985 Jul; 14(7):619, 622-4. PubMed ID: 3899074
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hypertension complicated by coronary diseases and post-infarction hypertension].
    Kuramochi M
    Nihon Naika Gakkai Zasshi; 1990 Jan; 79(1):60-4. PubMed ID: 2324604
    [No Abstract]   [Full Text] [Related]  

  • 29. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
    Liedholm H; Ursing D
    Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
    Gysan DB
    Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors and physical activity levels at the onset of acute myocardial infarction in young men].
    Miyamoto S; Goto Y; Sumida H; Yasuda S; Matsumoto T; Morii I; Daikoku S; Itoh A; Miyazaki S; Nonogi H
    J Cardiol; 2000 Aug; 36(2):75-83. PubMed ID: 10955251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sports, physical activity and risk for coronary heart disease (author's transl)].
    Pfisterer M
    Z Kardiol; 1981 Feb; 70(2):104-10. PubMed ID: 7222903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of hypertension].
    Tretenhahn W
    Wien Med Wochenschr; 1966 May; 116(21):459-62. PubMed ID: 5987359
    [No Abstract]   [Full Text] [Related]  

  • 36. An Italian preventive trial of coronary heart disease: the Rome Project of Coronary Heart Disease Prevention.
    Menotti A
    Prog Biochem Pharmacol; 1983; 19():230-44. PubMed ID: 6828474
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].
    Demarchi PG; Mancini A; Brignole M; Astengo D; Bertulla A
    Minerva Cardioangiol; 1981 Dec; 29(12):719-28. PubMed ID: 7038536
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A; Unzueta A; Ordóñez Toquero G; Villasis Keever MA; Cocoletzi López J; Medina Santillán R
    Arch Inst Cardiol Mex; 2000; 70(6):589-95. PubMed ID: 11255718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.